Anaferon` Patent registered in the U.S.

U.S. Patent Office granted a patent for a unique composition, on the basis of which a popular Russian antiviral drug Anaferon is produced. So far, patents have been obtained only in Russia and CIS countries.

In Russia Anaferon and Anaferon for Children are among the most prescribed drugs by doctors for the prevention and treatment of influenza and ARVI, as well as a wide range of viral diseases.